Regentis Biomaterials Ltd. (RGNT)
1.30
-0.07
(-5.11%)
USD |
NYAM |
Nov 04, 15:40
Regentis Biomaterials Market Cap : 9.131M for Nov. 4, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 03, 2026 | 9.623M |
| November 02, 2026 | 9.623M |
| October 30, 2026 | 9.623M |
| October 29, 2026 | 9.552M |
| October 28, 2026 | 8.639M |
| October 27, 2026 | 9.061M |
| October 26, 2026 | 8.850M |
| October 23, 2026 | 8.991M |
| October 22, 2026 | 9.834M |
| October 21, 2026 | 10.47M |
| October 20, 2026 | 10.33M |
| October 19, 2026 | 10.40M |
| October 16, 2026 | 10.47M |
| October 15, 2026 | 10.89M |
| October 14, 2026 | 10.61M |
| October 13, 2026 | 11.41M |
| October 12, 2026 | 11.45M |
| October 09, 2026 | 11.24M |
| October 08, 2026 | 11.94M |
| October 07, 2026 | 11.45M |
| October 06, 2026 | 11.59M |
| October 05, 2026 | 11.73M |
| October 02, 2026 | 12.99M |
| October 01, 2026 | 12.85M |
| September 30, 2026 | 12.71M |
| Date | Value |
|---|---|
| September 29, 2026 | 12.99M |
| September 28, 2026 | 13.28M |
| September 25, 2026 | 13.91M |
| September 24, 2026 | 14.33M |
| September 23, 2026 | 14.75M |
| September 22, 2026 | 14.68M |
| September 21, 2026 | 15.66M |
| September 18, 2026 | 12.71M |
| September 17, 2026 | 12.29M |
| September 16, 2026 | 12.64M |
| September 15, 2026 | 12.71M |
| September 14, 2026 | 13.20M |
| September 11, 2026 | 13.28M |
| September 10, 2026 | 13.77M |
| September 09, 2026 | 14.12M |
| September 08, 2026 | 14.33M |
| September 04, 2026 | 10.20M |
| September 03, 2026 | 10.20M |
| September 02, 2026 | 10.46M |
| September 01, 2026 | 10.67M |
| August 31, 2026 | 10.57M |
| August 28, 2026 | 10.36M |
| August 27, 2026 | 10.67M |
| August 26, 2026 | 10.72M |
| August 25, 2026 | 10.82M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rosetta Genomics Ltd. | 0.0003M |
| Endonovo Therapeutics, Inc. | 0.1808M |
| CollPlant Biotechnologies Ltd. | 6.052M |
| Sisram Medical Ltd. | 25.85M |
| Elbit Medical Technologies Ltd. | 4.536M |
Market Cap Related Metrics
| Price | 1.30 |
| Earnings Yield | -188.7% |